{"id":"NCT00176878","sponsor":"Masonic Cancer Center, University of Minnesota","briefTitle":"Stem Cell Transplant for Bone Marrow Failure Syndromes","officialTitle":"Bone Marrow Transplantation for Non-Malignant Congenital Bone Marrow Failure Disorders","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2000-06","primaryCompletion":"2009-03","completion":"2009-03","firstPosted":"2005-09-15","resultsPosted":"2009-08-06","lastUpdate":"2017-12-28"},"enrollment":10,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diamond-Blackfan Anemia","Kostmann's Neutropenia","Shwachman-Diamond Syndrome"],"interventions":[{"type":"PROCEDURE","name":"Stem cell transplant","otherNames":["BMT"]},{"type":"DRUG","name":"Fludarabine monophosphate","otherNames":["Fludara"]},{"type":"PROCEDURE","name":"Total lymphoid irradiation","otherNames":["TLI"]},{"type":"DRUG","name":"Busulfan","otherNames":["Busulfex"]},{"type":"BIOLOGICAL","name":"anti-thymocyte globulin","otherNames":["ATG"]}],"arms":[{"label":"Bone Marrow Failure Disorders","type":"EXPERIMENTAL"}],"summary":"The researchers hypothesize that it will be possible to perform unrelated bone marrow or cord blood transplants in a safer manner by using less intensive therapy yet still achieve an acceptable level of donor cell engraftment for non-malignant congenital bone marrow failure disorders.","primaryOutcome":{"measure":"Number of Patients Alive (Survival) at 2 Years","timeFrame":"2 years","effectByArm":[{"arm":"Bone Marrow Failure Patients","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":10},"commonTop":[]}}